In this podcast, Dr Coyle discusses the "final word" on strategies to promote remyelination in multiple sclerosis from the ECTRIMS/ACTRIMS MSVirtual2020 meeting.
In this podcast, Dr Coyle discusses the "final word" on myelin oligodendrocyte glycoprotein-mediated disease in multiple sclerosis from the ECTRIMS/ACTRIMS MSVirtual2020 meeting.
In this podcast, Dr Coyle discusses the "final word" on neuromyelitis optica spectrum disorder in multiple sclerosis from the ECTRIMS/ACTRIMS MSVirtual2020 meeting.
At the ANA’s 145th Annual Meeting, Caterina Mainero, MD, PhD, discussed gray matter pathology in multiple sclerosis. After Dr Mainero’s presentation, Neurology Learning Network caught up with her about important research advances in this area.
In this podcast, Dr Zeydan discusses how multiple sclerosis (MS) phenotypes impact the association between aging and MS, key considerations for this patient population, and more. She recently discussed this topic at the ECTRIMS/ACTRIMS MSVirtual2020 meeting.
In this podcast, Dr Weber discusses clinical presentations of myelin oligodendrocyte glycoprotein-mediated disease in multiple sclerosis, as well as important research developments in this field. Dr Weber recently gave a talk about MOG-mediated disease in MS at the ECTRIMS/ACTRIMS MSVirtual2020 meeting.
Because no consensus currently exists for when and how aggressively to treat relapsing-remitting multiple sclerosis (RRMS), researchers compared the effects of early intensive treatment vs moderate-efficacy treatment followed by escalation among patients with RRMS. The findings were presented at MSVirtual2020.
Rituximab (RTX), an anti-CD20 monoclonal antibody, is commonly used as an off-label treatment for multiple sclerosis (MS). In a new study presented at MSVirtual2020, researchers compared the safety and efficacy of RTX at low and high doses among patients with MS.
Neurology Consultant spoke with Helen Tremlett, PhD, from the University of British Columbia, whose recent study adds to increasing evidence of a multiple sclerosis prodrome. Dr Tremlett discussed this topic during the Paty Lecture at the ECTRIMS/ACTRIMS 8th Joint Triennial Meeting, or MSVirtual2020.